Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05143073 · ClinicalTrials.gov registry record · NA

Understanding Genetic Risk for Alcohol Use Disorder

A NA study, sponsored by Virginia Commonwealth University.

Completed
Registry status
NA
Development phase
338
Enrollment target

NCT05143073 is a NA study that has completed, run by Virginia Commonwealth University. The registered enrollment target is 338 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05143073, a NA study, has completed, sponsored by Virginia Commonwealth University.

COMPLETED
Registry status
NA
Development phase
338 participants
Enrollment target

Study Summary

The purpose of this study is to evaluate an online educational tool that will help individuals better understand alcohol use disorder, risk factors, and genetic risk information and to better understand participant's beliefs regarding alcohol use disorder. This study does not involve genetic testing. Investigators will not be giving participants any personalized genetic feedback as part of the study; however, investigators will ask participants to imagine that they receive different hypothetical genetic risk scores and respond to survey items.

Interventions

  • BEHAVIORAL Alcohol use disorder and strategies to reduce risk educational material
  • BEHAVIORAL Complex polygenic risk scores, alcohol use disorder, and strategies to reduce risk educational material

Trial Details

FieldValue
Enrollment Target 338 participants
Start Date 2021-11-15
Est. Completion 2021-12-13
Phase NA

Sponsor

Virginia Commonwealth University

558 total trials

What the Registry Record Tells You About NCT05143073

The ClinicalTrials.gov registry entry for NCT05143073 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 338 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Alcohol use disorder and strategies to reduce risk educational material is the first listed.

NCT05143073 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05143073 about?

NCT05143073 is a clinical study titled "Understanding Genetic Risk for Alcohol Use Disorder". The purpose of this study is to evaluate an online educational tool that will help individuals better understand alcohol use disorder, risk factors, and genetic risk information and to better understand participant's beliefs regarding alcohol use disorder. This study does not involve genetic testing...

What is the current status of trial NCT05143073?

This trial is currently completed. It is a NA study. The enrollment target is 338 participants. The study started on 2021-11-15. Estimated completion is 2021-12-13.

What interventions are being tested in trial NCT05143073?

The interventions under investigation include: Alcohol use disorder and strategies to reduce risk educational material (BEHAVIORAL), Complex polygenic risk scores, alcohol use disorder, and strategies to reduce risk educational material (BEHAVIORAL).

Who is sponsoring clinical trial NCT05143073?

This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.